Clinical trial
Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients
NCT07045064 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 4, 2025
- Completion date
- March 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease requiring hemodialysis